half life of glp-1 agonists How long does it take for to start working: timeline from first dose to full results GLP-1 receptor agonists in the

Effects of glucagon-like peptide-1 receptor agonists on cardiovascular and renal outcomes: a meta-analysis and meta-regression analysis

Back Edwards, K, Li, X, Linvay, I (1 April 2023) 'Clinical and safety outcomes with GLP-1 receptor agonists and SGLT2 inhibitors in type 1 diabetes: A real-world study', The Journal of Clinical Endocrinology & Metabolism , 108/ 4, 92030

Aerosp Med Human Perf

For persistent bloating

"The underreported symptoms are leads that came from patients themselves, unprompted, and clinicians could potentially pay attention to them." Lyle Ungar, Professor in CIS and a co-author of the study, says social media can offer insight into concerns patients may not always bring up during medical visits